Long-term progno- sis of congenital heart defects: a systematic review. Int J Cardiol. 2008;131:25 32. S10.8-63. Engelfriet P, Boersma E, Oechslin E, et al. The spectrum of adult congenital heart disease in Europe: morbidity and mortality in a 5 year follow-up period. The Euro Heart Survey on adult congenital heart disease. Eur Heart J. 2005;26:2325 33. S10.8-64. Arya S, Kovach J, Singh H, et al. Arrhythmias and sudden death among older children and young adults following tetralogy of Fallot repair in the current era: are previously reported risk factors still applicable? Congenit Heart Dis. 2014;9:407 14. S10.8-65. Wu MH, Lu CW, Chen HC, et al. Arrhythmic burdens in patients with tetralogy of Fallot: a national database study. Heart Rhythm. 2015;12:604 9. S10.8-66. Baraona F, Valente AM, Porayette P, et al. Coronary arteries in child- hood heart disease: implications for management of young adults. J Clin Exp Cardiolog. suppl 8 2012 006. S10.8-67. Naimo PS, Fricke TA, Yong MS, et al. Outcomes of truncus arteriosus repair in children: 35 years of experience from a single institution. Semin Thorac Cardiovasc Surg. 2016;28:500 11. S10.8-68. Pundi KN, Pundi KN, Johnson JN, et al. Sudden cardiac death and late arrhythmias after the Fontan operation. Congenit Heart Dis. 2017;12:17 23. 11. DEFIBRILLATORS OTHER THAN TRANSVENOUS ICDS 11.1. Subcutaneous Implantable Cardioverter-Defibrillator S11.1-1. Bardy GH, Smith WM, Hood MA, et al. An entirely subcuta- neous implantable cardioverter-defibrillator. N Engl J Med. 2010;363:36 44. S11.1-2. Weiss R, Knight BP, Gold MR, et al. Safety and efficacy of a totally subcutaneous implantable-cardioverter defibrillator. Circulation. 2013;128:944 53. S11.1-3. Lambiase PD, Barr C, Theuns DA, et al. Worldwide experience with a totally subcutaneous implantable defibrillator: early results from the EFFORTLESS S-ICD Registry. Eur Heart J. 2014;35:1657 65. S11.1-4. Burke MC, Gold MR, Knight BP, et al. 